Specifically, subjects with AUD who had a prescription for GIP/GLP-1 RA had an incident alcohol intoxication rate that was 49%, 42%, and 42% lower, respectively, when stratified by type 2 diabetes, obesity, and type 2 diabetes and obesity (Table 3) [26]. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.